SCHEMBL97073

SCHEMBL97073

Cc1ccc(-c2noc(CCO)n2)c(C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.47
KDM4E B2RXH2 4/20 0.47
HPGD P15428 3/20 0.47
ALDH1A1 P00352 2/20 0.47
GAA P10253 2/20 0.47
HSD17B10 Q99714 2/20 0.47
APOBEC3A P31941 1/20 0.47
CTDSP1 Q9GZU7 1/20 0.47
APOBEC3G Q9HC16 1/20 0.47
GLA P06280 1/20 0.47
PGK1 P00558 1/20 0.46
RAB9A P51151 6/20 0.46
NPC1 O15118 5/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
SMN1; SMN2 Q16637 5/20 0.43
TP53 P04637 4/20 0.43
MAPK1 P28482 3/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
TSHR P16473 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL95088 0.88 NOTUM (0.49) MAPTKDM4EHPGDALDH1A1GAA
SCHEMBL97072 0.85 MAPT (0.50) MAPTKDM4EHPGDALDH1A1GAA
SCHEMBL95087 0.83 MAPT (0.49) MAPTKDM4EHPGDALDH1A1GAA
SCHEMBL3939329 0.82 PGK1 (0.46) MAPTKDM4EHPGDALDH1A1GAA
SCHEMBL12759453 0.79 RAB9A (0.49) MAPTKDM4EHPGDALDH1A1GAA
SCHEMBL19835591 0.78 TDP1 (0.62) MAPTHPGDRAB9ANPC1MEN1
SCHEMBL3932295 0.77 RAB9A (0.71) MAPTGLARAB9ANPC1MEN1
SCHEMBL12601899 0.76 NPC1 (0.54) MAPTKDM4EHPGDALDH1A1GAA
SCHEMBL8016715 0.74 RAB9A (0.53) MAPTKDM4EHPGDALDH1A1GAA
SCHEMBL96233 0.72 CA1 (0.46) MAPTKDM4EHPGDALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20090326008-A1 NF-kappa B Inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-12-31 US disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326008-A1 NF-kappa B Inhibitor NFKBIA, NFKB2, IKBKB MAPT 4112/4885KDM4E 1125/4885HPGD 2146/4885
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 MAPT 4773/4885KDM4E 3919/4885HPGD 2322/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 MAPT 4773/4885KDM4E 3919/4885HPGD 2322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.